Pegoraro C, Bondavalli C, Molani L, Capitanio A, Schiavon L, Dall'Oglio B, Luciano M, Negri S
Regione Lombardia, Ospedale Multizonale di Mantova.
Arch Ital Urol Nefrol Androl. 1991 Jun;63 Suppl 2:127-9.
139 patients underwent urinary cytology and bladder sonography in follow-up of superficial bladder cancer (Ta G1-3) alternatively or at the same time of cystoscopy. Medium follow-up was 27.2 mos. In 7.91% there was progression to T1 o T2 but no case escaped this protocol. In 9% urinary cytology and bladder sonography were both falsely negative: tumors were smaller than 0.5 cm and low grade. In 76 patients with Tar bladder cystoscopy rate was 1/5.2 mos. before this study and 1/7.2 mos. after this study. In our opinion this protocol reveals the recurrence of superficial bladder tumor, reduce cystoscopy rate with no risk of ignored progression.
139例浅表性膀胱癌（Ta G1-3）患者在膀胱镜检查的同时或交替进行尿液细胞学检查和膀胱超声检查以进行随访。中位随访时间为27.2个月。7.91%的患者进展为T1或T2期，但无一例逃脱该方案。9%的患者尿液细胞学检查和膀胱超声检查均为假阴性：肿瘤小于0.5 cm且分级较低。在76例Ta期膀胱肿瘤患者中，本研究前膀胱镜检查率为每5.2个月1次，本研究后为每7.2个月1次。我们认为该方案可发现浅表性膀胱肿瘤的复发，降低膀胱镜检查率且无忽略病情进展的风险。
